# A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-study-of-bez235-in-patients-with-everolimus-resistant-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicola Fazio,Roberto Buzzoni,Éric Baudin,Lorenzo Antonuzzo,Richard Hubner,Harald Lahner,Wouter W. de Herder,Markus Raderer,Àlex Teulé,Jaume Capdevila,Steven K. Libutti,Matthew H. Kulke,Manisha H. Shah,Debarshi Dey,Sabine Turri,Paola Aimone,Cristian Massacesi,Chris Verslype |
| Citations | 86 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://hdl.handle.net/2158/1193479 |
| OpenAlex ID | https://openalex.org/W2264980831 |
| PMID | 26851029 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Harald Lahner](https://scholariq.org/researchers/harald-lahner/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

## Paper topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.